Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Role of SMPD3 during Bone Fracture Healing and Regulation of Its Expression.

Manickam G, Moffatt P, Murshed M.

Mol Cell Biol. 2019 Feb 4;39(4). pii: e00370-18. doi: 10.1128/MCB.00370-18. Print 2019 Feb 15.

PMID:
30530524
2.

Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice.

Rauch F, Geng Y, Lamplugh L, Hekmatnejad B, Gaumond MH, Penney J, Yamanaka Y, Moffatt P.

Bone. 2018 Feb;107:131-142. doi: 10.1016/j.bone.2017.11.013. Epub 2017 Nov 22.

PMID:
29174564
3.

The osteogenic cell surface marker BRIL/IFITM5 is dispensable for bone development and homeostasis in mice.

Patoine A, Husseini A, Kasaai B, Gaumond MH, Moffatt P.

PLoS One. 2017 Sep 7;12(9):e0184568. doi: 10.1371/journal.pone.0184568. eCollection 2017.

4.

Interactions of AMTN, ODAM and SCPPPQ1 proteins of a specialized basal lamina that attaches epithelial cells to tooth mineral.

Fouillen A, Dos Santos Neves J, Mary C, Castonguay JD, Moffatt P, Baron C, Nanci A.

Sci Rep. 2017 Apr 24;7:46683. doi: 10.1038/srep46683.

5.

Absence of the dermatan sulfate chain of decorin does not affect mouse development.

Moffatt P, Geng Y, Lamplugh L, Nanci A, Roughley PJ.

J Negat Results Biomed. 2017 Apr 17;16(1):7. doi: 10.1186/s12952-017-0074-3.

6.

Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta.

Bardai G, Ward LM, Trejo P, Moffatt P, Glorieux FH, Rauch F.

Osteoporos Int. 2017 Jul;28(7):2095-2101. doi: 10.1007/s00198-017-4031-2. Epub 2017 Apr 4.

PMID:
28378289
7.

DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum.

Bardai G, Moffatt P, Glorieux FH, Rauch F.

Osteoporos Int. 2016 Dec;27(12):3607-3613. Epub 2016 Aug 11.

PMID:
27509835
8.

Smpd3 Expression in both Chondrocytes and Osteoblasts Is Required for Normal Endochondral Bone Development.

Li J, Manickam G, Ray S, Oh CD, Yasuda H, Moffatt P, Murshed M.

Mol Cell Biol. 2016 Aug 12;36(17):2282-99. doi: 10.1128/MCB.01077-15. Print 2016 Sep 1.

9.

Laminin γ2 knockout mice rescued with the human protein exhibit enamel maturation defects.

Wazen RM, Viegas-Costa LC, Fouillen A, Moffatt P, Adair-Kirk TL, Senior RM, Nanci A.

Matrix Biol. 2016 May-Jul;52-54:207-218. doi: 10.1016/j.matbio.2016.03.002. Epub 2016 Mar 5.

PMID:
26956061
10.

Osteogenesis Imperfecta Type VI in Individuals from Northern Canada.

Ward L, Bardai G, Moffatt P, Al-Jallad H, Trejo P, Glorieux FH, Rauch F.

Calcif Tissue Int. 2016 Jun;98(6):566-72. doi: 10.1007/s00223-016-0110-1. Epub 2016 Jan 27.

PMID:
26815784
11.

Osteogenesis Imperfecta Type I Caused by COL1A1 Deletions.

Bardai G, Lemyre E, Moffatt P, Palomo T, Glorieux FH, Tung J, Ward L, Rauch F.

Calcif Tissue Int. 2016 Jan;98(1):76-84.

PMID:
26478226
12.

Inactivation of the Odontogenic ameloblast-associated gene affects the integrity of the junctional epithelium and gingival healing.

Wazen RM, Moffatt P, Ponce KJ, Kuroda S, Nishio C, Nanci A.

Eur Cell Mater. 2015 Sep 28;30:187-99.

13.

Recessive osteogenesis imperfecta caused by missense mutations in SPARC.

Mendoza-Londono R, Fahiminiya S, Majewski J; Care4Rare Canada Consortium, Tétreault M, Nadaf J, Kannu P, Sochett E, Howard A, Stimec J, Dupuis L, Roschger P, Klaushofer K, Palomo T, Ouellet J, Al-Jallad H, Mort JS, Moffatt P, Boudko S, Bächinger HP, Rauch F.

Am J Hum Genet. 2015 Jun 4;96(6):979-85. doi: 10.1016/j.ajhg.2015.04.021. Epub 2015 May 28.

14.

The effect of SERPINF1 in-frame mutations in osteogenesis imperfecta type VI.

Al-Jallad H, Palomo T, Roughley P, Glorieux FH, McKee MD, Moffatt P, Rauch F.

Bone. 2015 Jul;76:115-20. doi: 10.1016/j.bone.2015.04.008. Epub 2015 Apr 11.

PMID:
25868797
15.

Cole-Carpenter syndrome is caused by a heterozygous missense mutation in P4HB.

Rauch F, Fahiminiya S, Majewski J, Carrot-Zhang J, Boudko S, Glorieux F, Mort JS, Bächinger HP, Moffatt P.

Am J Hum Genet. 2015 Mar 5;96(3):425-31. doi: 10.1016/j.ajhg.2014.12.027. Epub 2015 Feb 12.

16.

A framework for estimating health state utility values within a discrete choice experiment: modeling risky choices.

Robinson A, Spencer A, Moffatt P.

Med Decis Making. 2015 Apr;35(3):341-50. doi: 10.1177/0272989X14554715. Epub 2014 Oct 27.

PMID:
25349189
17.

A polyadenylation site variant causes transcript-specific BMP1 deficiency and frequent fractures in children.

Fahiminiya S, Al-Jallad H, Majewski J, Palomo T, Moffatt P, Roschger P, Klaushofer K, Glorieux FH, Rauch F.

Hum Mol Genet. 2015 Jan 15;24(2):516-24. doi: 10.1093/hmg/ddu471. Epub 2014 Sep 11.

PMID:
25214535
18.

Characterisation of secretory calcium-binding phosphoprotein-proline-glutamine-rich 1: a novel basal lamina component expressed at cell-tooth interfaces.

Moffatt P, Wazen RM, Dos Santos Neves J, Nanci A.

Cell Tissue Res. 2014 Dec;358(3):843-55. doi: 10.1007/s00441-014-1989-3. Epub 2014 Sep 6.

PMID:
25193156
19.

Normal bone density and fat mass in heterozygous SERPINF1 mutation carriers.

Al-Jallad H, Palomo T, Moffatt P, Roughley P, Glorieux FH, Rauch F.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2446-50. doi: 10.1210/jc.2014-2505. Epub 2014 Aug 15.

PMID:
25127091
20.

Targeted sequencing of a pediatric metabolic bone gene panel using a desktop semiconductor next-generation sequencer.

Rauch F, Lalic L, Glorieux FH, Moffatt P, Roughley P.

Calcif Tissue Int. 2014 Oct;95(4):323-31. doi: 10.1007/s00223-014-9897-9. Epub 2014 Aug 3.

PMID:
25086671
21.

Osteogenic cell cultures cannot utilize exogenous sources of synthetic polyphosphate for mineralization.

Ariganello MB, Omelon S, Variola F, Wazen RM, Moffatt P, Nanci A.

J Cell Biochem. 2014 Dec;115(12):2089-102. doi: 10.1002/jcb.24886.

PMID:
25043819
22.

Skeletal characteristics associated with homozygous and heterozygous WNT1 mutations.

Palomo T, Al-Jallad H, Moffatt P, Glorieux FH, Lentle B, Roschger P, Klaushofer K, Rauch F.

Bone. 2014 Oct;67:63-70. doi: 10.1016/j.bone.2014.06.041. Epub 2014 Jul 8.

PMID:
25010833
23.

Topological mapping of BRIL reveals a type II orientation and effects of osteogenesis imperfecta mutations on its cellular destination.

Patoine A, Gaumond MH, Jaiswal PK, Fassier F, Rauch F, Moffatt P.

J Bone Miner Res. 2014 Sep;29(9):2004-16. doi: 10.1002/jbmr.2243.

24.

Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics.

Fahiminiya S, Majewski J, Al-Jallad H, Moffatt P, Mort J, Glorieux FH, Roschger P, Klaushofer K, Rauch F.

J Bone Miner Res. 2014 Aug;29(8):1805-14. doi: 10.1002/jbmr.2208.

25.

A brilliant breakthrough in OI type V.

Lazarus S, Moffatt P, Duncan EL, Thomas GP.

Osteoporos Int. 2014 Feb;25(2):399-405. doi: 10.1007/s00198-013-2465-8. Epub 2013 Sep 13. Review.

PMID:
24030286
26.

Expression of odontogenic ameloblast-associated and amelotin proteins in the junctional epithelium.

Nishio C, Wazen R, Moffatt P, Nanci A.

Periodontol 2000. 2013 Oct;63(1):59-66. doi: 10.1111/prd.12031. Review.

PMID:
23931054
27.

Osteogenesis imperfecta, an ever-expanding conundrum.

Glorieux FH, Moffatt P.

J Bone Miner Res. 2013 Jul;28(7):1519-22. doi: 10.1002/jbmr.1982. No abstract available.

28.

Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation.

Kasaai B, Gaumond MH, Moffatt P.

J Biol Chem. 2013 May 10;288(19):13278-94. doi: 10.1074/jbc.M113.457010. Epub 2013 Mar 24.

29.

Mutations in WNT1 are a cause of osteogenesis imperfecta.

Fahiminiya S, Majewski J, Mort J, Moffatt P, Glorieux FH, Rauch F.

J Med Genet. 2013 May;50(5):345-8. doi: 10.1136/jmedgenet-2013-101567. Epub 2013 Feb 23.

PMID:
23434763
30.

Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly is caused by a duplication in RUNX2.

Moffatt P, Ben Amor M, Glorieux FH, Roschger P, Klaushofer K, Schwartzentruber JA, Paterson AD, Hu P, Marshall C; FORGE Canada Consortium, Fahiminiya S, Majewski J, Beaulieu CL, Boycott KM, Rauch F.

Am J Hum Genet. 2013 Feb 7;92(2):252-8. doi: 10.1016/j.ajhg.2012.12.001. Epub 2013 Jan 3.

31.

Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients.

Rauch F, Moffatt P, Cheung M, Roughley P, Lalic L, Lund AM, Ramirez N, Fahiminiya S, Majewski J, Glorieux FH.

J Med Genet. 2013 Jan;50(1):21-4. doi: 10.1136/jmedgenet-2012-101307.

PMID:
23240094
32.

Can weight-related health risk be more accurately assessed by BMI, or by gender specific calculations of Percentage Body Fatness?

Goacher PJ, Lambert R, Moffatt PG.

Med Hypotheses. 2012 Nov;79(5):656-62. doi: 10.1016/j.mehy.2012.08.003. Epub 2012 Aug 30.

PMID:
22939766
33.

Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI.

Rauch F, Husseini A, Roughley P, Glorieux FH, Moffatt P.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1550-6. doi: 10.1210/jc.2012-1827. Epub 2012 Jun 5.

PMID:
22669302
34.

A co-occurrence of osteogenesis imperfecta type VI and cystinosis.

Tucker T, Nelson T, Sirrs S, Roughley P, Glorieux FH, Moffatt P, Schlade-Bartusiak K, Brown L, Rauch F.

Am J Med Genet A. 2012 Jun;158A(6):1422-6. doi: 10.1002/ajmg.a.35319. Epub 2012 Apr 23.

PMID:
22528245
35.

Mechanical stress induces bone formation in the maxillary sinus in a short-term mouse model.

Kuroda S, Wazen R, Moffatt P, Tanaka E, Nanci A.

Clin Oral Investig. 2013 Jan;17(1):131-7. doi: 10.1007/s00784-012-0686-4. Epub 2012 Feb 29.

PMID:
22373776
36.

Spatial and temporal localization of WNT signaling proteins in a mouse model of distraction osteogenesis.

Kasaai B, Moffatt P, Al-Salmi L, Lauzier D, Lessard L, Hamdy RC.

J Histochem Cytochem. 2012 Mar;60(3):219-28. doi: 10.1369/0022155411432010.

37.

Odontogenic ameloblast-associated and amelotin are novel basal lamina components.

Dos Santos Neves J, Wazen RM, Kuroda S, Francis Zalzal S, Moffatt P, Nanci A.

Histochem Cell Biol. 2012 Mar;137(3):329-38. doi: 10.1007/s00418-011-0901-4. Epub 2012 Jan 10.

PMID:
22231912
38.

Ameloblastin is not implicated in bone remodelling and repair.

Kuroda S, Wazen R, Sellin K, Tanaka E, Moffatt P, Nanci A.

Eur Cell Mater. 2011 Jul 15;22:56-66; discussion 66-7.

39.

Requirements for ion and solute transport, and pH regulation during enamel maturation.

Lacruz RS, Smith CE, Moffatt P, Chang EH, Bromage TG, Bringas P Jr, Nanci A, Baniwal SK, Zabner J, Welsh MJ, Kurtz I, Paine ML.

J Cell Physiol. 2012 Apr;227(4):1776-85. doi: 10.1002/jcp.22911.

40.

Hyaluronan production by means of Has2 gene expression in chondrocytes is essential for long bone development.

Moffatt P, Lee ER, St-Jacques B, Matsumoto K, Yamaguchi Y, Roughley PJ.

Dev Dyn. 2011 Feb;240(2):404-12. doi: 10.1002/dvdy.22529. Epub 2011 Jan 3.

41.

P44-expression pattern of APIN and amelotin during formation and regeneration of the junctional epithelium.

Nishio C, Wazen R, Kuroda S, Moffatt P, Nanci A.

Bull Group Int Rech Sci Stomatol Odontol. 2011 Apr 11;49(3):111-2. No abstract available.

PMID:
22750383
42.
43.

Disruption of periodontal integrity induces expression of apin by epithelial cell rests of Malassez.

Nishio C, Wazen R, Kuroda S, Moffatt P, Nanci A.

J Periodontal Res. 2010 Dec;45(6):709-13. doi: 10.1111/j.1600-0765.2010.01288.x.

PMID:
20572917
44.

A mouse model expressing a truncated form of ameloblastin exhibits dental and junctional epithelium defects.

Wazen RM, Moffatt P, Zalzal SF, Yamada Y, Nanci A.

Matrix Biol. 2009 Jun;28(5):292-303. doi: 10.1016/j.matbio.2009.04.004. Epub 2009 Apr 16.

45.

Osteocrin--beyond just another bone protein?

Moffatt P, Thomas GP.

Cell Mol Life Sci. 2009 Apr;66(7):1135-9. doi: 10.1007/s00018-009-8716-3. Review. No abstract available.

PMID:
19234809
46.

[Osteocrin is a new signaling molecule acting on bone].

Moffatt P.

Med Sci (Paris). 2008 Oct;24(10):794-6. doi: 10.1051/medsci/20082410794. French. No abstract available.

47.

Bril: a novel bone-specific modulator of mineralization.

Moffatt P, Gaumond MH, Salois P, Sellin K, Bessette MC, Godin E, de Oliveira PT, Atkins GJ, Nanci A, Thomas G.

J Bone Miner Res. 2008 Sep;23(9):1497-508. doi: 10.1359/jbmr.080412.

48.

Hospice: the heart of end-of-life-care.

Moffatt P.

Int J Palliat Nurs. 2007 Oct;13(10):508-9. No abstract available.

PMID:
18073711
49.

Osteocrin is a specific ligand of the natriuretic Peptide clearance receptor that modulates bone growth.

Moffatt P, Thomas G, Sellin K, Bessette MC, Lafrenière F, Akhouayri O, St-Arnaud R, Lanctôt C.

J Biol Chem. 2007 Dec 14;282(50):36454-62. Epub 2007 Oct 19.

50.

Characterization of Apin, a secreted protein highly expressed in tooth-associated epithelia.

Moffatt P, Smith CE, St-Arnaud R, Nanci A.

J Cell Biochem. 2008 Feb 15;103(3):941-56.

PMID:
17647262

Supplemental Content

Loading ...
Support Center